سامانه جستجوی جامع منابع دانشگاه علوم پزشکی جندی شاپور اهواز



عنوان مقاله کنفرانس : M34 Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the tomorrow and inpulsis trials

ناشر : BMJ Publishing Group Ltd and British Thoracic Society

DOI کد :

10.1136/thoraxjnl-2017-210983.478

سال انتشار : 2017

نوع : مقاله کنفرانس

لینک خروجی به مقاله کنفرانس

@incollection{1,
    doi = {10.1136/thoraxjnl-2017-210983.478},
    url = {http://dx.doi.org/10.1136/thoraxjnl-2017-210983.478},
    year = 2017,
    publisher = {BMJ Publishing Group Ltd and British Thoracic Society},
    pages = {},
    author = {},
    title = {M34 Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the tomorrow and inpulsis trials}
}
TY  - DATA
DO  - 10.1136/thoraxjnl-2017-210983.478
UR  - http://dx.doi.org/10.1136/thoraxjnl-2017-210983.478
TI  - M34 Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the tomorrow and inpulsis trials
PY  - 2017
PB  - BMJ Publishing Group Ltd and British Thoracic Society
SP  - 
AU  -
, T. (2017). M34 Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the tomorrow and inpulsis trials. doi:10.1136/thoraxjnl-2017-210983.478
“M34 Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the tomorrow and inpulsis trials.” (2017)